政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

预告！推广三明医改经验新闻发布会今天下午将在福建省三明市召开

2021-07-06 国家卫健委 国家卫健委

三明医改
关注

国务院医改领导小组秘书处、国家卫生健康委定于2021年7月6日15:30在福建省三明市召开新闻发布会，请国家卫生健康委体制改革司、福建省卫生健康委、三明市人民政府、三明市沙县区总医院负责人介绍三明医改

国务院医改领导小组秘书处、国家卫生健康委定于2021年7月6日15:30在福建省三明市召开新闻发布会，请国家卫生健康委体制改革司、福建省卫生健康委、三明市人民政府、三明市沙县区总医院负责人介绍三明医改经验有关情况，并答记者问。

发布会将通过中国网进行图文直播，求是圆点直播、人民日报健康客户端、央视新闻新媒体等进行视频直播。

敬请关注！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655078, encodeId=8dda16550e8e1, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Thu Jan 27 22:34:32 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052641, encodeId=49e3205264112, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Mar 05 05:34:32 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287137, encodeId=a9f8128e13704, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515363, encodeId=2ec7151536335, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587416, encodeId=8014158e416d7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2022-01-27 ewsr9

    #福建省#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1655078, encodeId=8dda16550e8e1, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Thu Jan 27 22:34:32 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052641, encodeId=49e3205264112, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Mar 05 05:34:32 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287137, encodeId=a9f8128e13704, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515363, encodeId=2ec7151536335, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587416, encodeId=8014158e416d7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2022-03-05 宋威

    #发布会#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1655078, encodeId=8dda16550e8e1, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Thu Jan 27 22:34:32 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052641, encodeId=49e3205264112, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Mar 05 05:34:32 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287137, encodeId=a9f8128e13704, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515363, encodeId=2ec7151536335, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587416, encodeId=8014158e416d7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 tidiq

    #医改#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1655078, encodeId=8dda16550e8e1, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Thu Jan 27 22:34:32 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052641, encodeId=49e3205264112, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Mar 05 05:34:32 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287137, encodeId=a9f8128e13704, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515363, encodeId=2ec7151536335, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587416, encodeId=8014158e416d7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 12498adam43暂无昵称

    #三明医改#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1655078, encodeId=8dda16550e8e1, content=<a href='/topic/show?id=49d8e4680a4' target=_blank style='color:#2F92EE;'>#福建省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74680, encryptionId=49d8e4680a4, topicName=福建省)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1b24623883, createdName=ewsr9, createdTime=Thu Jan 27 22:34:32 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052641, encodeId=49e3205264112, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Mar 05 05:34:32 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287137, encodeId=a9f8128e13704, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515363, encodeId=2ec7151536335, content=<a href='/topic/show?id=99b5196642d' target=_blank style='color:#2F92EE;'>#三明医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19664, encryptionId=99b5196642d, topicName=三明医改)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd9410772172, createdName=12498adam43暂无昵称, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587416, encodeId=8014158e416d7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Thu Jul 08 05:34:32 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 zhangxingru

    #推广#

    0

相关资讯

追溯药品“灵魂砍价”源头：1300多批次近2万人次学习的三明医改做对了什么？

12月28日，国家医保局公布了调整后的国家医保药品目录，谈判成功的药品平均降价50.64%；2021年1月将公布新一轮“灵魂砍价”，更多药品将实现大幅降价。

三明医改，到底抓住了什么？

传染性疾病与健康问题拖慢了第一次工业革命步伐第一次工业革命是指从1760年前后至1860年左右期间发生的工业生产力革命性变化，这前后花了100年时间，来改造生产力。从18世纪中叶到19世纪初，英国5万人以上的城市从2个增加到24个， 全国1/3的人生活在2万人以上的城市里。至19世纪中叶，进入发达的工业化阶段。从17-20世纪，英国的国家人口数从490万增长至3090万。从人口的增长数据上就能

三明医改8年8个关键步骤，全国模板背后的经验复制

12月6日，国家卫健委在福建三明召开了新闻发布会，福建省卫健委党组书记黄如欣、三明市政府副市长张元明分别介绍了福建省和三明市的医改做法、进展及成效。

三明医改交出成绩单！国家要求大力推广，三医联动复制全国

三医联动改革或将全国复制。

招投标时代亲历者：三明没放起来的那把火，现在如何了？

每次遇到负责招投标事务的朋友，我都会很诡异地一笑……对方也都理解我的意思，说出我诡笑的含义：是啊，我工作的前景堪忧……但招投标还是在做啊……

“三明医改”屡获总理点赞，“三明健改”能否引领潮流？

国务院副总理、国务院医改领导小组组长孙春兰21日至23日在福建调研并出席医改推进现场会。她强调，要发挥三明医改典型引领作用，推动新时代医改走深走实、扩大成效。那么，三明市为什么能成为医改明星？三明经验能不能引领潮流？一、三明医改的典型引领作用有哪些孙春兰指出，三明市以调整医药目录、压缩药品耗材虚高价格为突破口，同步推进医疗、医保、医药联动改革，创新薪酬分配和监督考核，推动资源下沉和服务模式转变